| visual violet | A visual pigment, composed of 11-cis-retinal bound to an opsin, found in the cones of the retina. Synonym: visual violet. Origin: G. Ion, violet, + ops, eye, + -in (05 Mar 2000) |
|---|---|
| visual yellow | The orange retinaldehyde resulting from the action of light on the rhodopsin of the retina, which converts the 11-cis-retinal component of the rhodopsin to all-trans-retinal plus opsin. Synonym: trans-retinal, visual yellow. (05 Mar 2000) |
| primary visual area | Area of the occipital lobe concerned with vision. (12 Dec 1998) |
| primary visual cortex | See: visual cortex. (05 Mar 2000) |
| secondary visual area | Area of the occipital lobe concerned with vision. (12 Dec 1998) |
| secondary visual cortex | See: visual cortex. (05 Mar 2000) |
| unformed visual hallucination | Hallucination composed of sparks, lights, or bursting spheres of light. (05 Mar 2000) |
| formed visual hallucination | <psychiatry> Hallucination composed of scenes, often landscapes. (05 Mar 2000) |
| functional visual loss | An apparent loss of visual acuity or visual field with no substantiating physical signs; often due to a natural concern about visual loss combined with suggestibility and a fear of the worst; best treated with reassurance. (05 Mar 2000) |
| anamnestic response | <immunology> Archaic term now replaced by such terms as secondary immune response, immune memory. (18 Nov 1997) |
| auditory brainstem response audiometry | An electrophysiologic measure of auditory function utilizing responses produced by the auditory nerve and the brainstem to repetitive acoustic stimuli. (05 Mar 2000) |
| biological response modifier | <pharmacology, oncology> A substance used in adjuvant therapy that takes advantage of the bodys own natural defense mechanisms to inhibit the growth of a tumour. (16 Dec 1997) |
| biological response modifiers | Substances that stimulate the body's response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts and use them in cancer treatment. Also called BRMs. (12 Dec 1998) |
| biphasic response | Two separate and distinct responses that are separated in time, immediate reaction to an antigenic challenge followed by a recurrence of symptoms after an interval of quiescence. (05 Mar 2000) |
| booster response | The response of the immune system to the second or subsequent occasion on which it encounters a specific antigen. (18 Nov 1997) |